About SET domain-containing protein 4
SET domain-containing protein 4 (SETD4) is a protein
from Homo sapiens identified by UniProt accession
Q9NVD3, 440 residues long.
MolForge cross-references it against 0 known binders and
44 disease associations.
Target properties
| Protein name | SET domain-containing protein 4 |
| UniProt accession | Q9NVD3 |
| Gene | SETD4 |
| Organism | Homo sapiens |
| Length | 440 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (44)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.42
- C-reactive protein measurement · score 0.40
- IGF-1 measurement · score 0.34
- blood protein measurement · score 0.29
- Mitral valve prolapse · score 0.20
- insulin like growth factor measurement · score 0.13
- heel bone mineral density · score 0.07
- alkaline phosphatase measurement · score 0.05
- bone density · score 0.04
- hyperinsulinism due to INSR deficiency · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NVD3-F1 | alphafold | PREDICTED | 93.08 | — |
Amino-acid sequence (440 residues)
MQKGKGRTSR IRRRKLCGSS ESRGVNESHK SEFIELRKWL KARKFQDSNL APACFPGTGR GLMSQTSLQE GQMIISLPES CLLTTDTVIR SYLGAYITKW KPPPSPLLAL CTFLVSEKHA GHRSLWKPYL EILPKAYTCP VCLEPEVVNL LPKSLKAKAE EQRAHVQEFF ASSRDFFSSL QPLFAEAVDS IFSYSALLWA WCTVNTRAVY LRPRQRECLS AEPDTCALAP YLDLLNHSPH VQVKAAFNEE THSYEIRTTS RWRKHEEVFI CYGPHDNQRL FLEYGFVSVH NPHACVYVSR EILVKYLPST DKQMDKKISI LKDHGYIENL TFGWDGPSWR LLTALKLLCL EAEKFTCWKK VLLGEVISDT NEKTSLDIAQ KICYYFIEET NAVLQKVSHM KDEKEALINQ LTLVESLWTE ELKILRASAE TLHSLQTAFT
Explore SET domain-containing protein 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets